Approach to Diagnosis and Management of Hypertension: A Comprehensive and Combined Pediatric and Adult Perspective

医学 血压 肾脏疾病 盐皮质激素受体 疾病 肥胖 儿科 内科学 重症监护医学 醛固酮 内分泌学
作者
Sabine Karam,Debbie L. Cohen,Pauline Abou Jaoude,Janis M. Dionne,FangChao Linda Ding,Anika Garg,Elliot Koranteng Tannor,Rahul Chanchlani
出处
期刊:Seminars in Nephrology [Elsevier]
卷期号:43 (4): 151438-151438 被引量:1
标识
DOI:10.1016/j.semnephrol.2023.151438
摘要

The global prevalence of primary hypertension has been increasing both in children and in the adolescent and adult populations and can be attributed to changes in lifestyle factors with an obesity epidemic, increased salt consumption, and sedentary lifestyles. Childhood blood pressure is the strongest predictor of adult hypertension. Although hypertension in adults is associated strongly with an increased risk for cardiovascular disease, chronic kidney disease, and mortality, outcomes in children are defined less clearly. In adults, major guidelines agree on a threshold of less than 120/80 mm Hg as the optimal blood pressure (BP) and recommend a target of less than 130/80 mm Hg for treatment in most cases. In children, international pediatric guidelines recommend using thresholds based on the normative distribution of BP in healthy normal-weight children. Out-of-office BP assessment is extremely useful for confirming the diagnosis of hypertension and monitoring response to treatment. Lifestyle modifications are instrumental whether coupled or not with pharmacologic management. New agents such as nonsteroidal mineralocorticoid-receptor antagonists, aminopeptidase A inhibitors, aldosterone synthase inhibitors, and dual endothelin antagonists hold significant promise for resistant hypertension. The transition from pediatric to adult care can be challenging and requires careful planning and effective coordination within a multidisciplinary team that includes patients and their families, and pediatric and adult providers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_Z729Mn完成签到,获得积分10
2秒前
琉璃完成签到,获得积分10
2秒前
2秒前
2秒前
风趣雪一完成签到,获得积分10
2秒前
MXL完成签到,获得积分20
3秒前
葳蕤苍生发布了新的文献求助10
3秒前
xiuxiuxiuxiu完成签到,获得积分10
4秒前
hhhhhhan616完成签到,获得积分10
4秒前
悦泽瞬亦发布了新的文献求助10
5秒前
研友_Z729Mn发布了新的文献求助20
5秒前
6秒前
7秒前
sskaze完成签到 ,获得积分10
7秒前
美妮发布了新的文献求助10
7秒前
8秒前
大个应助白凌风采纳,获得10
8秒前
小刘医生完成签到,获得积分10
8秒前
乐乐应助研友_GZbO18采纳,获得10
9秒前
10秒前
11秒前
蟹蟹完成签到,获得积分10
11秒前
wy发布了新的文献求助10
11秒前
YC完成签到,获得积分10
12秒前
冲冲发布了新的文献求助10
13秒前
15秒前
浮游应助科研通管家采纳,获得10
15秒前
小蘑菇应助科研通管家采纳,获得10
15秒前
Ava应助科研通管家采纳,获得10
15秒前
浮游应助科研通管家采纳,获得10
15秒前
ccm应助科研通管家采纳,获得10
15秒前
JamesPei应助科研通管家采纳,获得10
16秒前
无花果应助科研通管家采纳,获得10
16秒前
小蘑菇应助初一采纳,获得10
16秒前
Lucas应助科研通管家采纳,获得10
16秒前
在水一方应助科研通管家采纳,获得10
16秒前
Jasper应助科研通管家采纳,获得10
16秒前
ccm应助科研通管家采纳,获得10
16秒前
bkagyin应助科研通管家采纳,获得10
16秒前
mashibeo应助科研通管家采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Treatise on Geochemistry (Third edition) 1600
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
List of 1,091 Public Pension Profiles by Region 981
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5458264
求助须知:如何正确求助?哪些是违规求助? 4564362
关于积分的说明 14294784
捐赠科研通 4489268
什么是DOI,文献DOI怎么找? 2458946
邀请新用户注册赠送积分活动 1448790
关于科研通互助平台的介绍 1424442